Updates are available Correction dated 2023-11-09
Click to view Correction: https://doi.org/10.1186/s12885-023-11606-7
-
Authors
Lococo, Filippo
Boldrini, Luca
Diepriye, Charles-Davies
Evangelista, Jessica
Nero, Camilla
Flamini, Sara
Minucci, Angelo
De Paolis, Elisa
Vita, Emanuele
Cesario, Alfredo
Annunziata, Salvatore
Calcagni, Maria Lucia
Chiappetta, Marco
Cancellieri, Alessandra
Larici, Anna Rita
Cicchetti, Giuseppe
Troost, Esther G.C.
Ádány, Róza
Farré, Núria
Öztürk, Ece
Van Doorne, Dominique
Leoncini, Fausto
Urbani, Andrea
Trisolini, Rocco
Bria, Emilio
Giordano, Alessandro
Rindi, Guido
Sala, Evis
Tortora, Giampaolo
Valentini, Vincenzo
Boccia, Stefania
Margaritora, Stefano
Scambia, Giovanni
- License Information
-
More Information
Article History
Received: 17 April 2023
Accepted: 22 May 2023
First Online: 13 June 2023
Change Date: 9 November 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1186/s12885-023-11606-7
Declarations
:
: The protocol of the study that has been proposed to you has been drawn up in accordance with the Standards of Good Clinical Practice of the European Union and the current review of the Helsinki Declaration and has been approved by the Ethics Committee of this structure. All methods will be carried out in accordance with relevant guidelines and regulations. The informed consent will be obtained from all subjects and/or their legal guardian(s). Approval of Fondazione Policlinico Universitario Agostino Gemelli IRCCS – Università Cattolica del Sacro Cuore Ethics Committee Number: 5420 − 0002485/23; Trial registration - clinicaltrial.gov: NCT05802771.
: A specific written consent (already validated by Fondazione Policlinico Universitario Agostino Gemelli IRCCS – Università Cattolica del Sacro Cuore Ethics Committee) will be acquired by each patient before starting the enrollment. A copy form is at disposal in 3 different languages.
: Evis Sala declares being a consultant for GE Healthcare and co-founder and shareholder of Lucida Medical. The other authors declare that they have no competing interests.
